9月17日晚间重要公告一览

Group 1 - China Ping An completed stock purchase under the 2025 long-term service plan, acquiring 74.615 million H-shares, accounting for 0.412% of total share capital, with a total transaction amount of 3.875 billion yuan [1] - New China Life Insurance reported original insurance premium income of 158.086 billion yuan from January to August, representing a year-on-year increase of 21% [7] - Longhua Group received a project development notification from a domestic automaker, with an estimated total sales amount of approximately 280 million yuan over a 5-year project lifecycle [8] Group 2 - Tianlong Co., Ltd. announced that its general manager plans to reduce holdings by up to 320,000 shares, representing 0.16% of total share capital, due to personal financial needs [2] - Pingzhi Information became a candidate for a 170 million yuan AI computing power technology service project [3] - Shandong Mining announced the establishment of a holding subsidiary with a registered capital of 10 million yuan, in which it holds a 65% stake [4] Group 3 - Haixia Environmental Protection plans to invest 60.6059 million yuan in upgrading a sewage treatment project [5] - Zaiqi Pharmaceutical received approval for clinical trials of its injection drug ZGGS34 for treating MUC17 positive advanced solid tumors [6] - Hengrui Medicine's application for a new indication for SHR-A1811 for HER2 positive breast cancer was accepted and included in the priority review process [16][17] Group 4 - Vanke A received a loan support of 2.064 billion yuan from its largest shareholder, Shenzhen Metro Group, for debt repayment [38] - Guang'an Aizhong plans to acquire 90% of Qitai Hengzong at a price of 0 yuan to expand its wind power business [39] - A total of 6 products from Jiuzhang Bio received IVDR CE certification, valid until September 10, 2030 [20]